1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Eye Drops Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Eye Drops Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Eye Drops Market Regional Analysis
6.2 North America Eye Drops Market Revenue 2020-2030 (US$ Million)
6.3 North America Eye Drops Market Forecast Analysis
7. North America Eye Drops Market Analysis – by Type
7.1 Antibiotics
- 7.1.1 Overview
- 7.1.2 Antibiotics: North America Eye Drops Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Artificial Tears
- 7.2.1 Overview
- 7.2.2 Artificial Tears: North America Eye Drops Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Hormones
- 7.3.1 Overview
- 7.3.2 Hormones: North America Eye Drops Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America Eye Drops Market Analysis – by Application
8.1 Eye Diseases
- 8.1.1 Overview
- 8.1.2 Eye Diseases: North America Eye Drops Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Eye Care
- 8.2.1 Overview
- 8.2.2 Eye Care: North America Eye Drops Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America Eye Drops Market Analysis – by Purchase Mode
9.1 OTC
- 9.1.1 Overview
- 9.1.2 OTC: North America Eye Drops Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Prescription
- 9.2.1 Overview
- 9.2.2 Prescription : North America Eye Drops Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America Eye Drops Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Eye Drops Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.2.1.1 North America Eye Drops Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 US: North America Eye Drops Market Breakdown, by Type
- 10.2.1.1.2 US: North America Eye Drops Market Breakdown, by Application
- 10.2.1.1.3 US: North America Eye Drops Market Breakdown, by Purchase Mode
- 10.2.1.2 Canada:
North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Canada: North America Eye Drops Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America Eye Drops Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Eye Drops Market Breakdown, by Purchase Mode
- 10.2.1.3 Mexico :
North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Mexico : North America Eye Drops Market Breakdown, by Type
- 10.2.1.3.2 Mexico : North America Eye Drops Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Eye Drops Market Breakdown, by Purchase Mode
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 AbbVie Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Akorn Operating Company LLC
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Alcon AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bausch & Lomb Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Pfizer Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Prestige Consumer Healthcare Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Rohto Pharmaceutical Co Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Similasan Corp
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Eye Drops Market
